Patents by Inventor John D. Rioux

John D. Rioux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METABOLIC BIOMARKERS OF INFLAMMATORY BOWEL DISEASE
    Publication number: 20230349933
    Abstract: Disclosed are various lipid biomarkers of inflammatory bowel disease, including biomarkers for inflammatory bowel diseases including Crohn’s disease and Ulcerative colitis. Also disclosed are various biomarkers of disease location and/or disease behavior in inflammatory bowel disease. The present disclosure also provides methods of using the biomarkers, including methods for diagnosis of inflammatory bowel disease, methods of determining predisposition to inflammatory bowel disease, methods of monitoring progression/regression of inflammatory bowel disease, and methods of assessing efficacy of compositions for treating inflammatory bowel disease.
    Type: Application
    Filed: April 27, 2023
    Publication date: November 2, 2023
    Inventors: John D. RIOUX, Christine DES ROSIERS, Anik FOREST, Gabrielle BOUCHER, Romain FERRU-CLÉMENT
  • GLYCEROL AS A PREDICTOR OF GLUCOSE TOLERANCE
    Publication number: 20080319176
    Abstract: Novel alterations in the glycerol kinase gene are described. Also described are methods of predicting or assisting in the prediction of impaired glucose tolerance and type 2 diabetes mellitus.
    Type: Application
    Filed: February 25, 2008
    Publication date: December 25, 2008
    Inventors: Daniel Gaudet, John D. Rioux, Steve Arsenault, Thomas J. Hudson, Mark Daly
  • Glycerol as a predictor of glucose tolerance
    Publication number: 20040259134
    Abstract: Novel alterations in the glycerol kinase gene are described. Also described are methods of predicting or assisting in the prediction of impaired glucose tolerance and type 2 diabetes mellitus.
    Type: Application
    Filed: April 19, 2004
    Publication date: December 23, 2004
    Applicants: Whitehead Institute for Biomedical Research, Complexe Hospitalier de la Sagamie
    Inventors: Daniel Gaudet, John D. Rioux, Steve Arsenault, Thomas J. Hudson, Mark J. Daly
  • Glycerol as a predictor of glucose tolerance
    Patent number: 6743579
    Abstract: Novel alterations in the glycerol kinase gene are described. Also described are methods of predicting or assisting in the prediction of impaired glucose tolerance and type 2 diabetes mellitus.
    Type: Grant
    Filed: October 20, 2000
    Date of Patent: June 1, 2004
    Assignees: Whitehead Institute for Biomedical Research, Complexe Hospitalier de la Sagamie
    Inventors: Daniel Gaudet, John D. Rioux, Steve Arsenault, Thomas J. Hudson, Mark Daly
  • Haplotype map of the human genome and uses therefor
    Publication number: 20030170665
    Abstract: A method of producing a haplotype map which can be used to select an optimal set of single nucleotide polymorphic sites for examination in a subsequent genotyping study is disclosed, along with the map so produced.
    Type: Application
    Filed: August 5, 2002
    Publication date: September 11, 2003
    Applicant: Whitehead Institute for Biomedical Research
    Inventors: Mark J. Daly, David M. Altshuler, Eric S. Lander, John D. Rioux, Stacey B. Gabriel, Stephen Schaffner